Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

Aguirre, V. M. B., Rosales, C., Macías, C. L., & Gómez, M. I. (2014). Control and Resolution Mechanisms of the Inflammatory Response. Mediators of Inflammation, (2014-3), 476-477. https://doi.org/10.1155/2014/387567
Sears, B., & Ricordi, C. (2011). Anti-Inflammatory Nutrition as a Pharmacological Approach to Treat Obesity. Journal of Obesity, 2011(), 362-375. https://doi.org/10.1155/2011/431985
張寶琪、陳信宏、謝博軒、羅慶徽、朱紀洪（2005）。β-cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes and the Therapeutic Implication。中華職業醫學雜誌，12(4)，229-233。https://doi.org/10.30027/CJOM.200510.0003
Bolton, C., & Paul, C. (2006). Glutamate Receptors in Neuroinflammatory Demyelinating Disease. Mediators of Inflammation, 2006(), 495-506. https://doi.org/10.1155/MI/2006/93684
王思璇（2010）。Effects of Silymarin on Excess Glucose-boosted Inflammatory Responses〔碩士論文，臺北醫學大學〕。華藝線上圖書館。https://doi.org/10.6831/TMU.2010.00240